Summary
The biotechnology market in Asia-Pacific region looks very lucrative from investment perspective as it has enjoyed double-digit growth in past few years. The industry is attracting more and more private investments in wake of immense growth opportunities and vast untapped biotech markets. Identifying the future growth potential of the industry, the governments of different countries in the Asia-Pacific region are taking up various initiatives to promote research in the region. Overall, the Asia-Pacific biotech market is expected to spur future growth in the global biotechnology market.
According to our new research report, "Asia Pacific Biotechnology Market (2008-2012)", the Asia-Pacific biotech market is projected to grow at a CAGR of around 14% during 2010-2012. Currently, the industry is driven by new developing markets like Malaysia and India where developments in the sector are on a full swing. Anticipating the future growth, governments are promoting the industry by making investments and implementing new strategies.
Our research has found that Japan and China are dominating the industry. While higher growth rate has been witnessed in emerging markets like Malaysia, Japan and China are anticipated to dominate the market in future with combined share of around 70% of overall market. In this regard, our report provides rational analysis of various factors which will drive this market over the forecast period.
The report also provides extensive information and data of the biotech market in the Asia-Pacific region as well as discusses the emerging trends like contract research and manufacturing, bioinformatics, generics market etc. It provides valuable information to pharmaceutical & biotechnology companies and investors looking to enter these markets and help them to devise strategies in accordance to the individual markets. The report also contains detailed analysis and statistics of the market size, growth, share, segmentation, geographic distribution and trends in technology development.
Table of Contents
1. Analyst View
2. Global Biotechnology Industry Overview
2.1 Market Overview
2.1.1 Product Segmentation
2.1.2 Geographical Segmentation
3. Asia-Pacific Biotechnology Market
3.1 Market Overview
3.1.1 Product Segmentation
3.1.2 Geographical Segmentation
3.1.3 Future Outlook (2010-2012)
3.2 Key Market Drivers
3.2.1 Strong Government Support
3.2.2 Strong and Low Cost Human Resources
3.2.3 Bio-diversity
4. Biotechnology Market by Country
4.1 Japan
4.1.1 Market Overview
4.1.2 Product Segmentation
4.1.3 Bio-clusters
4.1.4 Success and Risk Factors
4.1.5 Future Outlook (2010-2012)
4.2 China
4.2.1 Market Overview
4.2.2 Product Segmentation
4.2.3 Bio-clusters
4.2.4 Success and Risk Factors
4.2.5 Future Outlook (2010-2012)
4.3 India
4.3.1 Market Overview
4.3.2 Product Segmentation
4.3.3 Bio-clusters
4.3.4 Success and Risk Factors
4.3.5 Future Outlook (2010-11 to 2012-13)
4.4 Australia
4.4.1 Market Overview
4.4.2 Bio-clusters
4.4.3 Success and Risk Factors
4.4.4 Future Outlook (2010-2012)
4.5 Taiwan
4.5.1 Market Overview
4.5.2 Bio-clusters
4.5.3 Success and Risk Factors
4.5.4 Future Outlook (2010-2012)
4.6 South Korea
4.6.1 Market Overview
4.6.2 Product Segmentation
4.6.3 Bio-clusters
4.6.4 Success and Risk Factors
4.6.5 Future Outlook (2010-2012)
4.7 New Zealand
4.7.1 Market Overview
4.7.2 Product Segmentation
4.7.3 Success and Risk Factors
4.7.4 Future Outlook (2010-2012)
4.8 Singapore
4.8.1 Market Overview
4.8.2 Bio-clusters
4.8.3 Success and Risk Factors
4.8.4 Future Outlook (2010-2012)
4.9 Malaysia
4.9.1 Market Overview
4.9.2 Success and Risk Factors
4.9.3 Future Outlook (2010-2012)
5. Emerging Sectors
5.1 Contract Research and Manufacturing
5.2 Vaccines
5.3 Generics
5.4 Stem Cell Research
5.5 Nanotechnology
5.6 Bioinformatics
6. Roadblocks
6.1 IPR Regime
6.2 Private Participation
6.3 Lack of Bioventures
6.4 Inadequate Investment
7. Future Roadmap
7.1 Government Support
7.2 Role of Private Sector
7.3 Mergers & Acquisitions
7.4 Infrastructure Improvement
8. Competitive Landscape
8.1 Invitrogen Corporation
8.2 Takara Holdings, Inc.
8.3 CSL Limited
8.4 Biota Holdings Limited
8.5 GlaxoSmithKline Plc
Lists of Figures:
Figure 2-1: Global-Biotechnology Market (Billion US$), 2007-2009
Figure 2-2: Global-Forecast for Biotechnology Market (Billion US$), 2010-2012
Figure 2-3: Global-Biotechnology Market by Segment (%), 2008
Figure 2-4: Global-Biotechnology Market by Region (%), 2008
Figure 3-1: Asia-Pacific-Biotechnology Market (Billion US$), 2008 & 2009
Figure 3-2: Asia-Pacific-Biotechnology Market by Segment (%), 2008
Figure 3-3: Asia-Pacific-Biotechnology Market by Country (%), 2008
Figure 3-4: Asia-Pacific-Forecast for Biotechnology Market (Billion US$), 2010-2012
Figure 3-5: Asia-Pacific-Forecast for Biotechnology Market by Country (%), 2012
Figure 4-1: Japan-Biotechnology Market (Billion JPY), 2008 & 2009
Figure 4-2: Japan-Biotechnology Market by Segment (%), 2007 & 2008
Figure 4-3: Japan-Medical and Healthcare Biotechnology Market by Segment (%), 2007
Figure 4-4: Japan-Geographical Distribution of Bio-clusters
Figure 4-5: Japan-Forecast for Biotechnology Market (Billion JPY), 2010-2012
Figure 4-6: China-Biotechnology Market (Billion US$), 2008 & 2009
Figure 4-7: China-Biotechnology Market by Segment (%), 2007
Figure 4-8: China-Forecast for Biotechnology Market (Billion US$), 2010-2012
Figure 4-9: India-Investment in Biotechnology Market (Million US$), 2006-07 to 2008-09
Figure 4-10: India-Biotechnology Market (Billion INR), 2008-09 & 2009-10
Figure 4-11: India-Export and Domestic Consumption of Biotechnology Market (%), 2008-09
Figure 4-12: India-Biotech Companies by Segment (%), 2006-07
Figure 4-13: India-Biotechnology Market by Segment (%), 2008-09
Figure 4-14: India-Biopharmaceutical Market by Segment (%), 2006-07
Figure 4-15: India-Geographical Distribution of Bio-clusters
Figure 4-16: India-Forecast for Biotechnology Market (Billion INR), 2010-11 to 2012-13
Figure 4-17: India-Forecast for Biotechnology Market by Segment (%), 2012-13
Figure 4-18: Australia-Biotechnology Market (Million US$), 2008 & 2009
Figure 4-19: Australia-Biotech Companies by Sector (%), June 2008
Figure 4-20: Australia-Geographical Distribution of Bio-clusters
Figure 4-21: Australia-Forecast for Biotechnology Market (Million US$) 2010-2012
Figure 4-22: Taiwan-Investment in Biotechnology Market (Million US$), 2006 & 2007
Figure 4-23: Taiwan-Biotechnology Market (Billion US$), 2008 & 2009
Figure 4-24: Taiwan-Forecast for Biotechnology Market (Billion US$), 2010-2012
Figure 4-25: South Korea-Biotechnology Market (Billion US$), 2007-2009
Figure 4-26: South Korea-Biotechnology Market by Segment (%)
Figure 4-27: South Korea-Geographical Distribution of Bio-clusters
Figure 4-28: South Korea-Forecast for Biotechnology Market (Billion US$), 2010-2012
Figure 4-29: New Zealand-Biotechnology Market (Million US$), 2008 & 2009
Figure 4-30: New Zealand-Biotechnology Market by Segment (%)
Figure 4-31: New Zealand-Biotech Companies by Sector (%), 2007
Figure 4-32: New Zealand-Geographical Distribution of Bio-clusters (2005)
Figure 4-33: New Zealand-Forecast for Biotechnology Market (Million US$), 2010-2012
Figure 4-34: Singapore-Biotechnology Market (Million US$), 2008 & 2009
Figure 4-35: Singapore-Geographical Distribution of Bio-clusters
Figure 4-36: Singapore-Forecast for Biotechnology Market (Million US$), 2010-2012
Figure 4-37: Malaysia-Biotechnology Market (Million RM), 2008 & 2009
Figure 4-38: Malaysia-Biotech Companies by Segment (%), 2008
Figure 4-39: Malaysia-Forecast for Biotechnology Market (Million RM), 2010-2012
Figure 5-1: India-Contract Research Market (Million US$), 2007, 2008 & 2010
Figure 5-2: India-Contract Manufacturing Market (Million US$), 2007, 2008 & 2010
Figure 5-3: Asia-Pacific-Generics Market (Billion US$), 2007-2009
Figure 5-4: Global-Use of Nanoparticles in Biomedical Applications (Million US$), 2007 & 2013
Lists of Tables:
Table 3-1: Asia-Pacific-Top 10 Biotech Companies
Table 4-1: Japan-Biotechnology Market by Segment (Billion JPY), 2007 & 2008
Table 4-2: India-Top 20 Biotech Companies by Revenue (Billion INR), 2008-09
Table 4-3: South Korea-Growth in Major Segments of Biotechnology Market (%), 1999-2004
